Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.1025
-0.0019 (-1.82%)
May 26, 2026, 12:56 PM EST
Zomedica Revenue
Zomedica had revenue of $8.80M in the quarter ending March 31, 2026, with 35.37% growth. This brings the company's revenue in the last twelve months to $34.33M, up 24.73% year-over-year. In the year 2025, Zomedica had annual revenue of $32.03M with 17.39% growth.
Revenue (ttm)
34.33M
Revenue Growth
+24.73%
P/S Ratio
2.98
Revenue / Employee
243.47K
Employees
141
Market Cap
102.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.03M | 4.75M | 17.39% |
| Dec 31, 2024 | 27.29M | 2.10M | 8.33% |
| Dec 31, 2023 | 25.19M | 6.26M | 33.05% |
| Dec 31, 2022 | 18.93M | 14.80M | 358.02% |
| Dec 31, 2021 | 4.13M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allurion Technologies | 12.60M |
| BioElectronics | 1.61M |
| PetVivo Holdings | 1.11M |
| Family Office of America | 1.00M |
| Guided Therapeutics | 767.00K |
| Tian'an Technology Group | 734.89K |
| Positron | 453.12K |
| CS Diagnostics | 204.00K |
Zomedica News
- 6 days ago - Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association - Accesswire
- 12 days ago - Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market - Accesswire
- 19 days ago - Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity - Accesswire
- 20 days ago - Zomedica Quarterly report: Q1 2026 - Filings
- 20 days ago - Zomedica Earnings release: Q1 2026 - Filings
- 4 weeks ago - Zomedica Proxy statement: Proxy filing - Filings
- 4 weeks ago - Zomedica Proxy statement: Proxy filing - Filings
- 5 weeks ago - Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale - Accesswire